Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 242
Selected: 0
NCT IDTitle
NCT07089186Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae Infections
NCT05555212To Evaluate the Efficacy of QLH11811 in Advanced NSCLC Patients With EGFR Mutation
NCT06383767A Phase III Study of ESG401 for Locally Advanced or Metastatic HR+/HER2- Breast Cancer
NCT06822985QL1706 As Second-line Treatment in Patients with Advanced Hepatocellular Carcinoma
NCT07040826Lifitegrast Eye Drops in Healthy Subjects:Phase I Study
NCT06754644A Study to Evaluate Efficacy, and Safety of QL2107 Plus Chemo and Compare With Keytruda in Participants With IV nqNSCLC
NCT05461287Safety, Tolerability and Pharmacokinetics Study of QLS31904 in Patients With Advanced Solid Tumors
NCT07327619A Study to Evaluate the Efficacy and Safety of Meropenem and Pralurbactam in HABP/VABP
NCT05621330Efficacy and Safety of QL0911 in Adult Patients With Chronic Primary Immune Thrombocytopenia
NCT05149924Efficacy and Safety of QL1012 in Women for Assisted Reproductive Treatment
NCT07138885A Phase II, Single-Arm, Prospective Trial on the Efficacy and Safety of QL1706 Combination Regimen as Second-Line Therapy for Targeted-Immunotherapy-Resistant Hepatocellular Carcinoma
NCT05487391A Study of QL1706 Combined With Platinum-containing Chemotherapy in Adjuvant Treatment of Stage II-IIIB Non-small Cell Lung Cancer After Complete Surgical Resection.
NCT06644495Post-Market Surveillance Study of ALK-Positive Advanced NSCLC Participants Treated With Iruplinalkib
NCT04651036A Phase 1 Study to Assess the Immunogenicity of QL0605 Compared to US Neulasta in Healthy Subjects
NCT07489586A Clinical Study of QL1207H Injection Versus Aflibercept for Neovascular Age-related Macular Degeneration
NCT05884801Phase I Study of QLS1103 in Subjects With Advanced Solid Tumors
NCT04486430Efficacy and Safety Study of Neu2000KWL for Acute Ischemic Stroke Patients Within 6 Hours of Onset
NCT05703204A Study of QLF32101 in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
NCT05823285A Study Evaluates the Safety, Pharmacokinetics, Immunogenicity and Efficacy of QLS31903 in Advanced Solid Tumor Patients
NCT05554913Evaluating the Efficacy and Safety of QL0911 in the Prevention of Chemotherapy- Induced Thrombocytopenia
NCT05329025A Study of QL1706 Combined With Chemotherapy in Advanced Non-small Cell Lung Cancer
NCT05830045A Phase I Study of QLP2117 in Subjects With Advanced Solid Tumors
NCT07467629QLS5212 for Participants With Advanced Solid Tumors
NCT04629846Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive and Estrogen Receptor/Progesterone Receptor Negative Breast Cancer to Evaluate the Efficiency and Safety of Treatment With Trastuzumab Plus (+) QL1209/Pertuzumab + Docetaxel.
NCT07018050Phase II Study of QLS32015 Combination Therapy in the Treatment of Multiple Myeloma
NCT07102004Study of MHB088C for Patients With Advanced Solid Malignant Tumors
NCT06942767Combination of QLS31905, QL2107 and Chemotherapy as First-line Therapy in CLDN18.2-positive Unresectable Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
NCT07235176Phase Ib/II Clinical Study of QLS1304 Combined With Endocrine Therapy in the Treatment of ER+/HER2- Breast Cancer Patients
NCT06151587A Phase 3 Clinical Study of QLM3004 in Delaying Myopia in Children
NCT07724756Phase II Study of QLC2519 in Pediatric Solid Tumor Participants
NCT03557580A Bioequivalence Study of Isosorbide-5-Mononitrate Extended-Release Tablets Under Fed Conditions in Healthy Subjects
NCT05055687Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous FL058 Administered in Healthy Subjects(SAD/MAD)
NCT07730632Phase II Clinical Study on the Efficacy and Safety of QLS7305 in Patients With Kidney Disease (Part A)
NCT07828873A Single-Arm Study of QL1706 Combined With DOS as Neoadjuvant Therapy for Locally Advanced Gastric/GEJ Adenocarcinoma
NCT06880276Efficacy and Safety Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis
NCT03195569To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in Study of QL1101 and Avastin® in Patients With Non-squamous Non-small Cell Lung Cancer
NCT07131345Study of Iparomlimab and Tuvonralimab Plus Chemotherapy in Malignant Mesothelioma
NCT07025239QL1706 Injection Plus Bevacizumab and XELOX vs Placebo Plus Bevacizumab and XELOX as First-Line Treatment of Unresectable Metastatic Colorectal Cancer
NCT06994507GM1 Prophylaxis for Nab-paclitaxel-associated Chemotherapy-induced Peripheral Neuropathy (CIPN) in Patients With Breast Cancer
NCT04705519Nab-paclitaxel Combined with Bevacizumab in the Treatment of Metastatic Extrapulmonary Neuroendocrine Carcinoma
NCT07001839A Phase Ib Study of QLS4131 in Subjects With Systemic Lupus Erythematosus
NCT07074236Pharmacokinetics and Pharmacodynamics Study
NCT06864793Study on the Pharmacokinetics and Safety of QL1012D and Gonal-F® in Healthy Female Volunteers
NCT05150405A Phase Ia Clinical Study of QLF31907 Injection in Patients With Advanced Malignant Tumors
NCT07173595A Phase I Study of QLS2309 Injection in Patients With CD70+ Relapsed/Refractory Hematologic Malignancies
NCT07127822Assessing Iparomlimab and Tuvonralimab in Recurrent or Metastatic MSI-H/dMMR Gastric Cancer
NCT06751277QL1706 Combined with Chemotherapy in the Treatment of Recurrent or Metastatic Endometrial Cancer
NCT04641754A Study Evaluates the Safety and Efficacy of WX-0593 in ALK -Positive, or ROS1-positive Non-small Cell Lung Cancer
NCT04954456A Study of Bispecific Antibody QLS31901 in Patients With Advanced or Metastatic Malignancies
NCT07004335Efficacy and Safety of Iparomlimab and Tuvonralimab Injection in Combination With Bevacizumab After Progression on Anti-PD-(L)1 Therapy in Advanced Melanoma: A Prospective, Single-Arm, Exploratory Clinical Study